OPK-88003

· OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPK-88003, covering 2021-06-15 to 2021-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects [Phase 2]